Accepted abstracts will be published online on this website two weeks prior to the conference as well as in the conference mobile app.
By submitting an abstract to an EASL event, you agree with the following statement:
“I hereby assign all copyrights to the European Association for the Study of the Liver (EASL), for the abstract submitted to the EASL monothematic conference on : “Striving towards the elimination of HCV” (government authors not electing to transfer, agree to assign an exclusive publishing and distribution license) and any supplemental tables, illustrations or other information submitted therewith that are intended for publication as part of the abstract in all forms and media (whether now known or hereafter developed), throughout the world, in all languages, for the full term of copyright, effective when, and if, the article is accepted for publication. This transfer includes the right to provide the abstract in electronic and online forms and systems.”
All abstracts that have been accepted for ePoster presentations require that at least one author attends the conference to present the work, and answer questions. EASL will offer ePoster format for all poster presentations. Full instructions concerning the preparation and presentation will be provided in the acceptance e-mail to be sent on 08 Dec 2017.